A multicomponent one-pot clean cyclocondensation reaction of 4-chloro-2-nitro aniline/amino acids and aromatic aldehydes/indole-2,3-diones with thiosemicarbazide in water yielding triazole/spiro indole-triazole derivatives in high yields and shorter reaction time and displaying excellent florescent property is reported. The developed MCR may provide a valuable practical tool for the synthesis of new drugs containing the title core fragment. All the newly synthesized compounds have been characterized by IR, 1HNMR, 13CNMR, and fluorescence study and also been screened for antimicrobial activity. 1. Introduction Multicomponent and domino reactions are efficient and effective methods in the sustainable and diversity-oriented synthesis of heterocycles and such reactions have attracted enormous interest in recent years [1]. Thiosemicarbazide and its derivatives are an important class of synthetic compounds, having large variety of applications due to their wide spectrum of biological activities [2] including antiviral [3] and antitumoral [4] as well as parasiticidal activity against Plasmodium falciparum, Plasmodium berghei [5], Trypanosoma cruzi [6–8] Trypanosoma brucei rhodesiense [9], and Toxoplasma gondii [10]. The 1,2,4-triazoles and their derivatives are found to be associated with various biological activities such as anticonvulsant [11], antifungal [12], anticancer [13], antiinflammatory [14], and antibacterial properties [15]. Also several compounds containing 1,2,4-triazole rings are well known as drugs; for example, fluconazole is used as an antimicrobial drug, while vorozole, letrozole, and anastrozole are nonsteroidal drugs used for the treatment of cancer. The increasing diversity of small molecule libraries is an important source for the discovery of new drug candidates. In terms of this trend, the literature survey showed that indole derivatives possess anticancer [16, 17], antioxidant [18], antibacterial [19], antifungal [20, 21], antiviral [22, 23], and antihypertensive activities [24]. Indole-3-carbon atom in the form of spiro carbon atom exhibits enhanced biological activities [25, 26]. The important biological activities of triazole derivatives impelled us to take up the synthesis of these new combinational heterocycles which are likely to have augmented diverse biological activity. The developed MCR may provide a valuable practical tool for the synthesis of novel physiologically active agents containing the title core fragment. Several methods [27–30] for the synthesis of 1,2,4-triazole derivatives are reported in the literature but all
References
[1]
T. J. J. Müller, “Multicomponent reactions,” Beilstein Journal of Organic Chemistry, vol. 7, pp. 960–961, 2011.
[2]
R. P. Tenório, C. S. Carvalho, C. S. Pessanha, et al., “Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity,” Bioorganic & Medicinal Chemistry Letters, vol. 15, pp. 2575–2578, 2005.
[3]
M. C. Pirrung, S. V. Pansare, K. Das Sarma, K. A. Keith, and E. R. Kern, “Combinatorial optimization of isatin-β-thiosemicarbazones as anti-poxvirus agents,” Journal of Medicinal Chemistry, vol. 48, no. 8, pp. 3045–3050, 2005.
[4]
W.-X. Hu, W. Zhou, C.-N. Xia, and X. Wen, “Synthesis and anticancer activity of thiosemicarbazones,” Bioorganic & Medicinal Chemistry Letters, vol. 16, pp. 2213–2218, 2006.
[5]
R. B. de Oliveira, E. M. de Souza-Fagundes, R. P. P. Soares, A. A. Andrade, A. U. Kretti, and C. L. Zani, “Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives,” European Journal of Medicinal Chemistry, vol. 43, pp. 183–188, 2008.
[6]
A. Pérez-Rebolledo, L. R. Teixeira, A. A. Batista, et al., “4-Nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity,” European Journal of Medicinal Chemistry, vol. 43, pp. 939–948, 2008.
[7]
G. Aguirre, L. Boiani, H. Cerecetto et al., “In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones,” Bioorganic and Medicinal Chemistry, vol. 12, no. 18, pp. 4885–4893, 2004.
[8]
X. Du, C. Guo, E. Hansell et al., “Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain,” Journal of Medicinal Chemistry, vol. 45, no. 13, pp. 2695–2707, 2002.
[9]
N. Fujii, J. P. Mallari, E. J. Hansell et al., “Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 1, pp. 121–123, 2005.
[10]
R. P. Tenório, A. J. S. Góes, J. G. de Lima, A. R. de Faria, A. J. Alves, and T. M. Aquino, “Thiosemicarbazones: preparation methods, synthetic applications and biological importance,” Química Nova, vol. 28, pp. 1030–1037, 2005.
[11]
J. M. Kane, B. M. Baron, M. W. Dudley, S. M. Sorensen, M. A. Staeger, and F. P. Miller, “2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents,” Journal of Medicinal Chemistry, vol. 33, no. 10, pp. 2772–2777, 1990.
[12]
S. Rollas, N. Kalyoncuoglu, D. Sur-Altiner, and Y. Yegenoglu, “5-(4-Aminophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione s: synthesis and antibacterial and antifungal activities,” Pharmazie, vol. 48, no. 4, pp. 308–309, 1993.
[13]
B. E. Gilbert and V. Knight, “Biochemistry and clinical applications of ribavirin,” Antimicrobial Agents and Chemotherapy, vol. 30, no. 2, p. 201, 1986.
[14]
P. C. Wade, B. Richard Vogt, T. P. Kissick, L. M. Simpkins, D. M. Palmer, and R. C. Millonig, “1-Acyltriazoles as antiinflammatory agents,” Journal of Medicinal Chemistry, vol. 25, no. 3, pp. 331–333, 1982.
[15]
F. Malbec, R. Milcent, P. Vicart, and A. M. Bure, “Synthesis of new derivatives of 4-amino-2,4-dihydro-1,2,4-triazol-3-one as potential antibacterial agents,” Journal of Heterocyclic Chemistry, vol. 21, no. 6, pp. 1769–1774, 1984.
[16]
L. I. Kruse, D. L. Ladd, P. B. Harrsch et al., “Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues,” Journal of Medicinal Chemistry, vol. 32, no. 2, pp. 409–417, 1989.
[17]
S. Ram, D. S. Wise, L. L. Wotring, J. W. McCall, and L. B. Townsend, “Synthesis and biological activity of certain alkyl 5-(alkoxycarbonyl)-1H-benzimidazole-2-carbamates and related derivatives: a new class of potential antineoplastic and antifilarial agents,” Journal of Medicinal Chemistry, vol. 35, no. 3, pp. 539–547, 1992.
[18]
E. R. Cole, G. Crank, and A. Salam-Sheikh, “Antioxidant properties of benzimidazoles.,” Journal of Agricultural and Food Chemistry, vol. 22, no. 5, p. 918, 1974.
[19]
C. Hubschwerlen, P. Pflieger, J. L. Specklin et al., “Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors,” Journal of Medicinal Chemistry, vol. 35, no. 8, pp. 1385–1392, 1992.
[20]
P. Venkatesan, “Albendazole,” Journal of Antimicrobial Chemotherapy, vol. 41, pp. 145–147, 1998.
[21]
N. S. Pawar, D. S. Dalal, S. R. Shimpi, and P. P. Mahulikar, “Studies of antimicrobial activity of N-alkyl and N-acyl 2-(4-thiazolyl)-1H-benzimidazoles,” European Journal of Pharmaceutical Sciences, vol. 21, pp. 115–118, 2004.
[22]
T. Ishida, T. Suzuki, S. Hirashima et al., “Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole,” Bioorganic and Medicinal Chemistry Letters, vol. 16, pp. 1859–1863, 2006.
[23]
L. Garuti, M. Roberti, and G. Gentilomi, “Synthesis and antiviral assays of some benzimidazole nucleosides and acyclonucleosides,” Farmaco, vol. 56, no. 11, pp. 815–819, 2001.
[24]
K. Kubo, Y. Kohara, Y. Yoshimura et al., “Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids,” Journal of Medicinal Chemistry, vol. 36, no. 16, pp. 2343–2349, 1993.
[25]
K. Stratmann, R. E. Moore, R. Bonjouklian et al., “Welwitindolinones, unusual alkaloids from the blue-green algae Hapalosiphon welwitschii and Westiella intricata. Relationship to fischerindoles and hapalindoles,” Journal of the American Chemical Society, vol. 116, no. 22, pp. 9935–9942, 1994.
[26]
J. W. Skiles and D. Menil, “Spiro indolinone beta-lactams, inhibitors of poliovirus and rhinovlrus 3C-proteinases,” Tetrahedron Letters, vol. 31, p. 7277, 1990.
[27]
A. Hasan, N. F. Thomas, and S. Gapil, “Synthesis, characterization and antifungal evaluation of 5-substituted-4-amino-1,2,4-triazole-3-thioesters,” Molecules, vol. 16, no. 2, pp. 1297–1309, 2011.
[28]
S. Veda and H. Nagasawa, “Facile synthesis of 1,2,4-triazoles via a copper-catalyzed tandem addition-oxidative cyclization,” Journal of the American Chemical Society, vol. 131, pp. 15080–15081, 2009.
[29]
G. M. Castanedo, P. S. Seng, N. Blaquiere, S. Trapp, and S. T. Staben, “Rapid synthesis of 1,3,5-substituted 1,2,4-triazoles from carboxylic acids, amidines, and hydrazines,” Journal of Organic Chemistry, vol. 76, no. 4, pp. 1177–1179, 2011.
[30]
Y. Xu, M. Mc Laughlin, E. N. Bolton, and R. A. Reamer, “Practical synthesis of functionalized 1,5-disubstituted 1,2,4-triazole derivatives,” Journal of Organic Chemistry, vol. 75, pp. 8666–8669, 2010.
[31]
A. Dandia, P. Sarawgi, K. Arya, and S. Khaturia, “Mild and ecofriendly tandem synthesis of 1,2,4-triazolo[4,3-a]pyrimidines in aqueous medium,” Arkivoc, no. 16, pp. 83–92, 2006.
[32]
A. Jha, Y. L. N. Murthy, G. Durga, and T. T. Sundari, “Microwave-assisted synthesis of 3,5-Dibenzyl-4-amino-1,2,4-triazole and its diazo ligand, metal complexes along with anticancer activity,” E-Journal of Chemistry, vol. 7, no. 4, pp. 1571–1577, 2010.
[33]
A. Dandia, H. Sachdeva, and R. Singh, “Montmorillonite catalysed synthesis of novel spiro[3H-indole-3,3′- [3H-1,2,4] triazol]-2(1H) ones in dry media under microwave irradiation,” Journal of Chemical Research, vol. 2000, no. 6, pp. 272–275, 2000.
[34]
A. Dandia, R. Singh, S. Bhaskaran, and D. S. Shriniwas, “Versatile three-component procedure for combinatorial synthesis of biologically relevant scaffold spiro[indole-thiazolidinones] under aqueous conditions,” Green Chemistry, vol. 13, pp. 1852–1859, 2011.
[35]
T. K. Huang, R. Wang, S. Lin, and X. Lu, “Montmorillonite K-10: an efficient and reusable catalyst for the synthesis of quinoxaline derivatives in water,” Catalysis Communications, vol. 9, pp. 1143–1147, 2008.
[36]
G. P. Chiusoli, M. Costa, L. Cucchia, B. Gabriele, G. Salerno, and L. Veltri, “Carbon dioxide effect on palladium-catalyzed sequential reactions with carbon monoxide, acetylenic compounds and water,” Journal of Molecular Catalysis A, vol. 204-205, pp. 133–142, 2003.
[37]
M. Lautens and M. Yoshida, “Rhodium-catalyzed addition of arylboronic acids to alkynyl aza-heteroaromatic compounds in water,” Journal of Organic Chemistry, vol. 68, p. 762, 2003.
[38]
H. Kim, S. Lee, J. Lee, and J. Tae, “Rhodamine triazole-based fluorescent probe for the detection of Pt2+,” Organic Letters, vol. 12, no. 22, pp. 5342–5345, 2010.
[39]
S. Y. Park, J. H. Yoon, C. S. Hong et al., “A pyrenyl-appended triazole-based calix[4]arene as a fluorescent sensor for Cd2+ and Zn2+,” Journal of Organic Chemistry, vol. 73, no. 21, pp. 8212–8218, 2008.
[40]
J. D. Cheon, T. Mutai, and K. Araki, “Preparation of a series of novel fluorophores, N-substituted 6-amino and 6,6″-diamino-2,2′:6′,2″-terpyridine by palladium-catalyzed amination,” Tetrahedron Letters, vol. 47, no. 29, pp. 5079–5082, 2006.
[41]
S. Coe, W. K. Woo, M. Bawendi, and V. Bulovi？, “Electroluminescence from single monolayers of nanocrystals in molecular organic devices,” Nature, vol. 420, no. 6917, pp. 800–803, 2002.
[42]
G. Hughes and M. R. Bryce, “Electron-transporting materials for organic electroluminescent and electrophosphorescent devices,” Journal of Materials Chemistry, vol. 15, pp. 94–107, 2005.
[43]
M. R. Detty, S. L. Gibson, and S. J. Wagner, “Current clinical and preclinical photosensitizers for use in photodynamic therapy,” Journal of Medicinal Chemistry, vol. 47, no. 16, pp. 3897–3915, 2004.
[44]
H. Sachdeva, D. Dwivedi, R. R. Bhattacharjee, S. Khaturia, and R. Saroj, “NiO nanoparticles: an efficient catalyst for the multicomponent one-pot synthesis of novel spiro and condensed indole derivatives,” Journal of Chemistry, vol. 2013, Article ID 606259, 10 pages, 2013.
[45]
H. Sachdeva and D. Dwivedi, “Lithium-acetate-mediated biginelli one-pot multicomponent synthesis under solvent-free conditions and cytotoxic activity against the human lung cancer cell line A549 and breast cancer cell line MCF7,” The Scientific World Journal, vol. 2012, Article ID 109432, 9 pages, 2012.
[46]
H. Sachdeva, R. Saroj, S. Khaturia, and D. Dwivedi, “Operationally simple green synthesis of some Schiff bases using grinding chemistry technique and evaluation of antimicrobial activities,” Green Processing and Synthesis, vol. 1, pp. 469–477, 2012.
[47]
H. Sachdeva, D. Dwivedi, and S. Khaturia, “Aqua mediated facile synthesis of 2-(5/7-fluorinated-2-oxoindolin-3-ylidene)-N-(4-substituted phenyl) hydrazine carbothioamides,” Research Journal of Pharmaceutical, Biological and Chemical Science, vol. 2, no. 2, p. 213, 2011.
[48]
H. Sachdeva, R. Saroj, S. Khaturia, and H. L. Singh, “Comparative studies of lewis acidity of alkyl-tin chlorides in multicomponent biginelli condensation using grindstone chemistry technique,” Journal of the Chilean Chemical Society, vol. 57, no. 1, p. 1012, 2012.
[49]
S. Patil, S. D. Jadhav, and U. P. Patil, “Natural acid catalyzed synthesis of schiff base under solvent-free condition: as a green approach,” Archives of Applied Science Research, vol. 4, no. 2, pp. 1074–1078, 2012.
[50]
S. Patil, S. D. Jadhav, and M. B. Deshmukh, “Natural acid catalyzed synthesis of schiff base under solvent-free condition: as a green approach,” Archives of Applied Science Research, vol. 3, no. 1, pp. 203–208, 2011.
